title: Immunohistochemical characterization of macrophages and myofibroblasts in α-Naphthylisothiocyanate (ANIT)--induced bile duct injury and subsequent fibrogenesis in rats.
abstract: To investigate pathogenesis of post-bile duct (BD) injury fibrosis, interlobular BD epithelial injury was induced in male F344 rats by a single IP injection of α-naphthylisothiocyanate (75 mg/kg body weight) and rats were observed for 12 days. On days 1 to 2, cholangiocytes were injured and desquamated. On days 3 to 5, the affected BD began to regenerate, showing positive staining for CK19 and vimentin. On days 5 to 9, fibrotic areas gradually developed around regenerating BD in Glisson's sheath. These consisted of cells positive for vimentin, desmin, and α-SMA; vimentin- and desmin-positive cells were increased in early stage (days 1-3), whereas α-SMA-positive cells appeared in mid (days 4-7) and late stages (days 8-12), although there were cells coexpressing these cytoskeletons. On day 12, BD regeneration almost completed, with reduced fibrosis. Macrophages positive for ED2 (CD163) increased transiently in early stage, whereas those reacting to ED1 (CD68), OX6 (MHC II), and SRA-E5 (CD204) showed a consistent increase throughout the experiment. Interestingly, OX6-positive cells were limited to Glisson's sheath, whereas SRA-E5-positive cells were seen exclusively along sinusoids of hepatic lobules. MCP-1 mRNA increased significantly in early stage. This study shows that macrophages exhibiting different immunophenotypes and distributions participate in post-BD injury fibrosis associated with myofibroblasts expressing various mesenchymal cytoskeletons.
authors.affiliation: Veterinary Pathology, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, Osaka, Japan.
authors.forename: Hossain M
authors.initials: HM
authors.lastname: Golbar
authors.forename: Takeshi
authors.initials: T
authors.lastname: Izawa
authors.forename: Ryo
authors.initials: R
authors.lastname: Yano
authors.forename: Chisa
authors.initials: C
authors.lastname: Ichikawa
authors.forename: Osamu
authors.initials: O
authors.lastname: Sawamoto
authors.forename: Mitsuru
authors.initials: M
authors.lastname: Kuwamura
authors.forename: Jonathan
authors.initials: J
authors.lastname: Lamarre
authors.forename: Jyoji
authors.initials: J
authors.lastname: Yamate
mesh_terms: D015058:1-Naphthylisothiocyanate / Q000633:toxicity*; D000818:Animals; D001649:Bile Duct Diseases / Q000139:chemically induced* / Q000378:metabolism* / Q000473:pathology; D018932:Chemokine CCL2 / Q000378:metabolism; D003598:Cytoskeletal Proteins / Q000378:metabolism; D005355:Fibrosis / Q000139:chemically induced* / Q000378:metabolism / Q000473:pathology; D020869:Gene Expression Profiling; D007150:Immunohistochemistry; D008099:Liver / Q000187:drug effects / Q000473:pathology; D008111:Liver Function Tests; D008264:Macrophages / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D058628:Myofibroblasts / Q000187:drug effects* / Q000378:metabolism; D051381:Rats; D011916:Rats, Inbred F344; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: C491766:Ccl2 protein, rat; D018932:Chemokine CCL2; D003598:Cytoskeletal Proteins; D015058:1-Naphthylisothiocyanate